Stoke Therapeutics, Inc. (STOK) Earnings Call Transcripts

7 earnings calls from January 2022 to August 3, 2026

NasdaqGS US Health Care Biotechnology

About Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc. (STOK) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 7 calls on record spanning January 10, 2022 to August 3, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 7 Stoke Therapeutics, Inc. earnings call transcripts on record, spanning January 10, 2022 to August 3, 2026. Based on this history, Stoke Therapeutics, Inc. reports annually. The most recent call on file is dated August 3, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
STOK
Exchange
NasdaqGS
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
7
First call
January 10, 2022
Most recent
August 3, 2026
Reporting cadence
annually
Quarter Date
Q2 FY2026 Aug 3, 2026 Read transcript
Company Conference Presentations Jun 8, 2026 Read transcript
Q1 FY2026 May 7, 2026 Read transcript
Q2 FY2025 Aug 12, 2025 Read transcript
Company Conference Presentations Jan 15, 2025 Read transcript
Shareholder/Analyst Calls Nov 14, 2022 Read transcript
Company Conference Presentations Jan 10, 2022 Read transcript